Abstract
Vaccination with live attenuated influenza A virus (LAIV) has the potential to provide protection against the more severe consequences of pandemic flu regardless of subtype. This possibility should be explored.
MeSH terms
-
Animals
-
Disease Outbreaks
-
Humans
-
Influenza A virus / immunology*
-
Influenza Vaccines*
-
Influenza, Human / prevention & control*
-
Mice
-
Orthomyxoviridae Infections / prevention & control
-
T-Lymphocytes / immunology
-
Vaccines, Attenuated
Substances
-
Influenza Vaccines
-
Vaccines, Attenuated